BS 4 years programme, BPharm, MBBS, BVSc, Integrated BS- MS, MSc, BE, BTech or equivalent degree, with 55% marks and passing of NET, GATE test is Mandatory
Characterization of Novel Anti-BCMA Antibody Drug Conjugate as an Immunotherapeutic Agent for Multiple Myeloma. M.Pharm, ME, M.Tech degree holders with relevant experience in the cancer research. First Class Post Graduate degree MSc in life sciences, Biochemistry, Biotechnology, Microbiology, Molecular Oncology, including the integrated PG degree with three years of experience
Provide technical support to the DteGHS, Ministry of Health & Family Welfare by implementing the priorities of the WHO-Global Patient Safety Action Plan 2020-2030 & National Patient Safety Implementation Framework. Facilitate in coordination with the Center of excellence to include Patient Safety activities in their State PIPs under the guidance of MoHFW.
MBBS, Doctor of Pharmacy, M.Sc. Statistics, M.Sc. in Life Sciences with 2 years of experience in the field of systematic reviews, network meta-analysis is mandatory.
B.S. 4 years programme, B.Pharm, MBBS, Integrated BS-MS, M.Sc, BE, B.Tech or equivalent degree, with 55% marks and passing of NET, GATE test. Project FISHING OUT MECHANORESPONSIVE HYDROGELS THROUGH CHIRAL ORCHESTRATION IN AMOHIPHILIC PEPTIDES : A POTENTIAL THERAPEUTIC TO CANCER AND MICROBIAL CHALLENGES
Plan, operationalize, and coordinate the Health and Biomarker component of the LASI project in coordination with IIPS team. Manage the technical aspects of data validation, adherence to methodologies, and coordination with LASI head office staff. Monitoring and Evaluation Knowledge, Understanding of health monitoring and evaluation systems, including the definition and measurement of core health indicators.
Development and Evaluation of Dehydrozingerone-Silver sulfadiazine incorporated wound dressings for the effective repair of diabetic wounds. Research work on the synthesis, characterization, and biological evaluation of novel wound dressings and its in-vivo analysis using molecular mechanisms. Proficiency in animal handling, molecular biology techniques and strong communication skills are desirable.
MBBS, BDS Or M.Pharma, MPT, M.sc Nursing, M.sc in life Sciences or Equivalent. Or Graduate in life Sciences BAMS, BHMS, B.sc Nursing, BPT or Equivalent from recognized University with three years of experience recognized Institution.
Execute, monitor, report and interpret preclinical, clinical and BABE studies at CROs to support various regulatory submissions within targeted timelines, budgets, quality and regulatory guidelines; identify health hazard and assess risks associated with pharmaceuticals, chemicals, intermediates, impurities, etc. by toxicological review and derivation
Comprehensive sero-profiling post Ivermectin, Diethylcarbamazine and Albendazole administration: Designing endpoints for Lymphatic Filariasis elimination. M.Pharm., M.V.Sc., or equivalent degree with high academic attainment and at least two years research experience after M. Sc. etc.